Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Synergy Bafoon on Call
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4442503"]Amylin reps launched GLP-1 to the world. We educated our clients on the MOA, and it was a road we paved for all other companies....namely Novo Nordisk. Novo comes into the mix and slowly takes the market share. At best, it's was a 60/40 advantage with Victoza. However, Amylin maintained a strong presence, and with Bydureon and tenacity of Amylin reps, the ratio is now almost 50/50. It's an amazing thing when you think about it. This little company (Amylin) keeping up with the GIANT Novo, and doing it with far less (money, people, marketing, etc). At last count there were roughly 15 Novo reps in the territory I cover. And yet, they have a minimal advantage in TRx. Their advantage in market share occurred about six months. However, the trend is obvious with the Bydureon launch that their advantage is slowly going away. We will take back the GLP-1 share (Byetta/Bydureon) in the near future. Guess what? This great accomplishment without question goes into the camp of Legacy.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4442503"]Amylin reps launched GLP-1 to the world. We educated our clients on the MOA, and it was a road we paved for all other companies....namely Novo Nordisk. Novo comes into the mix and slowly takes the market share. At best, it's was a 60/40 advantage with Victoza. However, Amylin maintained a strong presence, and with Bydureon and tenacity of Amylin reps, the ratio is now almost 50/50. It's an amazing thing when you think about it. This little company (Amylin) keeping up with the GIANT Novo, and doing it with far less (money, people, marketing, etc). At last count there were roughly 15 Novo reps in the territory I cover. And yet, they have a minimal advantage in TRx. Their advantage in market share occurred about six months. However, the trend is obvious with the Bydureon launch that their advantage is slowly going away. We will take back the GLP-1 share (Byetta/Bydureon) in the near future. Guess what? This great accomplishment without question goes into the camp of Legacy.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Synergy Bafoon on Call
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Amylin
>
Synergy Bafoon on Call
>